指南与共识湿疹皮炎与荨麻疹

成人难治性特应性皮炎诊断检测指南

Guidelines for diagnostic testing in adults with presumed atopic dermatitis refractory to treatment.
指南 / 共识 · J Am Acad Dermatol · 2026-08-31

美国皮肤病学会发布指南,针对优化治疗后仍难治的疑似成人特应性皮炎(AD),由多学科专家组采用GRADE方法制定良好实践声明,建议对此类患者考虑重新进行诊断评估。

要点

  • 优化治疗后仍难治的成人疑似AD应考虑重新诊断评估
  • 治疗失败可能源于误诊或合并其他疾病
  • 该声明基于间接证据与专家共识

核心结论

  • 良好实践声明支持对优化治疗后无应答的成人疑似AD考虑诊断再评估。

研究设计与样本

  • 由多学科专家组采用GRADE方法制定,通过审查间接证据、评估利弊平衡并达成共识形成良好实践声明。

主要发现

  • 专家组制定了关于疑似AD治疗无应答成人诊断检查的良好实践声明。

临床怎么用

  • 对优化治疗后仍难治的成人疑似AD患者,可考虑重新进行诊断评估。

局限性

  • 该指南基于间接证据和专家共识,缺乏关于难治性AD诊断检查策略的直接实证数据。
  • 适用性可能因皮肤科和过敏专科诊疗可及性不同而异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While many adults diagnosed with atopic dermatitis (AD) achieve disease control with standard treatments, a subset of patients remains refractory to optimal management. In these cases, misdiagnosis or the presence of concomitant conditions may be contributing to treatment failure. OBJECTIVE: To provide evidence-informed guidance for the diagnostic workup of presumed adult AD unresponsive to optimized treatment. METHODS: An expert multidisciplinary workgroup applied Grading of Recommendations, Assessment, Development, and Evaluation methodology for issuing guidance on approaching suspected AD refractory to treatment by reviewing the indirect evidence, assessing the balance of benefits and harms, and reaching consensus. RESULTS: The workgroup developed a Good Practice Statement on the diagnostic workup of adults with presumed AD unresponsive to therapy. LIMITATIONS: This guidance is based on indirect evidence and expert consensus, as direct empirical data on diagnostic workup strategies for treatment-resistant AD are lacking. Applicability may vary depending on access to dermatologic and allergy specialist care. CONCLUSION: The Good Practice Statement supports consideration of diagnostic reassessment in cases of presumed AD in adults not responding to optimized treatment.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Sidbury R, Wu PA, Alikhan A, et al. Guidelines for diagnostic testing in adults with presumed atopic dermatitis refractory to treatment. J Am Acad Dermatol. 2026. PMID: 42678322. doi:10.1016/j.jaad.2026.07.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。